溶血栓药物的发展概况
An overview of development of thrombolytic drugs
杨正浩1
作者信息
- 1. 华中科技大学生命科学与技术学院,湖北武汉430074
- 折叠
摘要
近年来,对溶血栓药物的研究取得了较大进展.本文对包括尿激酶(urokinase,UK)、链激酶(streptokinase,SK)、组织型纤溶酶原激活剂(tissue type plasminogen activator,tPA)、葡激酶(straphylokinase,SaK)、纳豆激酶(nattok-inase,NK)、重组型纤溶酶原激活物在内的历代溶血栓药物的发展历程、基本性质、优缺点、溶血栓机制及发展方向作一综述.
Abstract
In recent years,the research on thrombolytic drugs has made a great progress.This article describes the development process,basic properties,advantages and disadvantages,thrombolytic mechanisms and prospects of successive thrombolytic drugs,including urokinase (UK),streptokinase (SK),tissue type plasminogen activator (tPA),straphylokinase (SaK),nattokinase (NK) and recombinant plasminogen activator.
关键词
血栓/溶血栓药/尿激酶/组织型纤溶酶原激活剂/重组型纤溶酶原激活物Key words
Blood clots/Thrombolytic drugs/Urokinase (UK)/Tissue type plasminogen activator (tPA)/Recombinant plasminogen activator引用本文复制引用
出版年
2015
NETL
NSTL
维普
万方数据